Kaleido Scope

Phase 3: Implementation

Working Group: Annual Work Plan 2025-2026Opens an external link. Phase 3: Implementation phase consists of taking immediate action on key priorities, such as issuing a request for proposal (RFQ)to ...
Nasdaq

Vigil Neuroscience, Inc. Reports Positive Phase 1 Data for VG-3927 and Outlines Upcoming Milestones in Alzheimer’s Disease and ALSP Treatment Programs

Vigil Neuroscience reported positive Phase 1 trial results for VG-3927 and plans a Phase 2 trial in Q3 2025. Vigil Neuroscience, Inc. announced promising outcomes from a Phase 1 clinical trial of ...
Kaleido Scope

Phase 3: Implementation

This phase marks the active execution of the SUCCESS strategic roadmap. It is structured into three interconnected parts and guided by a comprehensive governance framework to ensure alignment to ...